UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 632

Sortiert nach

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The American journal of medicine, 2012, Vol.125 (1), p.S3-S13

Pfaller, Michael A., MD

2012

Volltextzugriff (PDF)

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S79-S94

2019

Volltextzugriff (PDF)

Epidemiology of Invasive Mycoses in North America

Critical reviews in microbiology, 2010-02, Vol.36 (1), p.1-53

2010

Volltextzugriff (PDF)

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Volltextzugriff (PDF)

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

International journal of antimicrobial agents, 2020-01, Vol.55 (1), p.105799-105799, Article 105799

2020

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S47-S53

2019

Volltextzugriff (PDF)

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Future microbiology, 2016-01, Vol.11 (1), p.103-117

2016

Volltextzugriff (PDF)

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

International journal of antimicrobial agents, 2011-07, Vol.38 (1), p.65-69

2011

Volltextzugriff (PDF)

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Journal of Clinical Microbiology, 2011-01, Vol.49 (1), p.396-399

2011

Volltextzugriff (PDF)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4465-4468

2011

Volltextzugriff (PDF)

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2608-2616

2013

Volltextzugriff (PDF)

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Journal of Clinical Microbiology, 2013-01, Vol.51 (1), p.117-124

2013

Volltextzugriff (PDF)

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1065-1068

2013

Volltextzugriff (PDF)

Analysis of Candida auris fungemia at a single facility in Kenya

International journal of infectious diseases, 2019-08, Vol.85, p.182-187

2019

Volltextzugriff (PDF)

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.117-127

2021

Volltextzugriff (PDF)

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Journal of antibiotics, 2021-08, Vol.74 (8), p.519-527

2021

Volltextzugriff (PDF)

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Journal of antibiotics, 2015-09, Vol.68 (9), p.556-561

2015

Volltextzugriff (PDF)

1 – 25 von 632

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

KollektioneBooks on EBSCOhost

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(614)
Mit Volltextzugriff
(564)

Publikationsform

Sprache

Englisch
(632)
Japanisch
(81)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(482)
Life Sciences & Biomedicine
(463)
Humans
(346)
Microbiology
(326)
Biological And Medical Sciences
(284)
Infectious Diseases
(249)
Medical Sciences
(220)
Microbial Sensitivity Tests
(181)
Fundamental And Applied Biological Sciences. Psychology
(130)
Pharmacology. Drug Treatments
(128)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(123)
Antifungal Agents - Pharmacology
(120)
Pharmacology & Pharmacy
(102)
Anti-Bacterial Agents - Pharmacology
(81)
Mycology
(81)
Candida - Drug Effects
(79)
Antifungal Agents
(72)
Candida
(71)
Antibacterial Agents
(67)
Female
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Epidemiology of Invasive Mycoses in North America

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Analysis of Candida auris fungemia at a single facility in Kenya

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Aktive Filter

Suchergebnisse filtern